News
FDA Issues Draft Guidance for Clinical Trials Using Enrichment
Published January 14, 2013 by OSP
A new guidance document to support the approval of human drugs and biological products is intended to support effectiveness and safety claims in new drug applications (NDAs) and biologics licensed applications (BLAs).
